Commission Regulation (EC) No 1231/2006 of 16 August 2006 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards ceftiofur and polyoxyethylene sorbitan monooleate and trioleate (Text with EEA relevance)

ANNEXU.K.

A.The following substance is inserted in Annex I to Regulation (EEC) No 2377/90 (List of pharmacologically active substances for which maximum residue limits have been fixed):U.K.

1.Anti-infectious agentsU.K.

1.2.AntibioticsU.K.

1.2.2.CephalosporinsU.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
^a For porcine species this MRL relates to “skin and fat in natural proportions”.’
‘Ceftiofur	Sum of all residues retaining the betalactam structure expressed as desfuroylceftiofur	All mammalian food-producing species	1 000 μg/kg	Muscle
			2 000 μg/kg	Fat^a
			2 000 μg/kg	Liver
			6 000 μg/kg	Kidney
			100 μg/kg	Milk

B.The following substance is inserted in Annex II to Regulation (EEC) No 2377/90 (List of substances not subject to maximum residue limits):U.K.

3.Substances generally recognised as safeU.K.

Pharmacologically active substance(s)	Animal species
‘Polyoxyethylene sorbitan monooleate and trioleate	All food-producing species’